Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages

  Zhang, Geng ^a   Sun, Qi ^b   Hu, Frank B ^b   Ye, Xingwang ^a   Yu, Zhijie ^c   Zong, Geng ^a   Li, Huaixing ^a   Zhou, Yunhua ^a   Lin, Xu ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BROCK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINA; CHINESE; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERTENSION; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OMEGA 3 FATTY ACID ERYTHROCYTE LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGE DISTRIBUTION; AGED; ALPHA-LINOLENIC ACID; ASIAN CONTINENTAL ANCESTRY GROUP; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84861994726     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2997     Document Type: Article

References (19)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752 (Pubitemid 41532612)
2. Yang W, Reynolds K, Gu D, Chen J, He J 2007 A comparison of two proposed definitions for metabolic syndrome in the Chinese adult population. Am J Med Sci 334:184-189 (Pubitemid 47414992)
3. Huang T, Bhulaidok S, Cai Z, Xu T, Xu F, Wahlqvist ML, Li D 2010 Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome. Mol Nutr Food Res 54:1628-1635
4. Lee E, Lee S, Park Y 2008 n-3 Polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: a case-control study in Korea. Br J Nutr 100:609-614
5. Warensjö E, Risérus U, Vessby B 2005 Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48:1999-2005 (Pubitemid 41416909)
6. Wang L, Tsai M, Manson JE, Djousse L, Gaziano JM, Buring JE, Sesso HD 2011 Erythrocyte fatty acid composition is associated with the risk of hypertension in middle-aged and older women. J Nutr 141:1691-1697
7. Zhang B, Wang P, Zhou Q, Chen C, Zhuo S, Ye Y, He Q, Chen Y, Su Y 2011 The relationships between erythrocyte membrane n-6 to n-3 polyunsaturated fatty acids ratio and blood lipids and C-reactive protein in Chinese adults: an observational study. Biomed Environ Sci 24:234-242
8. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X 2007 Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J AmColl Cardiol 49:1798-1805 (Pubitemid 46629126)
9. Zhai F, Yang Y 2006 The nutrition and health status of the Chinese people 2002: diet and nutrients intake. Beijing, China: People's Medical Publishing House
10. Yang Y 2005 Chinese Food Composition Table 2004. Beijing: Peking University Medical Press
11. Willett W, Stampfer MJ 1986 Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17-27 (Pubitemid 16095831)
12. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB 2007 Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86:74-81 (Pubitemid 47041595)
13. Kabagambe EK, Tsai MY, Hopkins PN, Ordovas JM, Peacock JM, Borecki IB, Arnett DK 2008 Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 54:154-162 (Pubitemid 351182609)
14. Anderson BM, Ma DW 2009 Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis 8:33
15. Wendland E, Farmer A, Glasziou P, Neil A 2006 Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92:166-169 (Pubitemid 43131951)
16. Lemaitre RN, King IB, Sotoodehnia N, Rea TD, Raghunathan TE, Rice KM, Lumley TS, Knopp RH, Cobb LA, Copass MK, Siscovick DS 2009 Red blood cell membrane α-linolenic acid and the risk of sudden cardiac arrest. Metabolism 58:534-540
17. Oomen CM, Ocké MC, Feskens EJ, Kok FJ, Kromhout D 2001 α-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr 74:457-463 (Pubitemid 32880255)
18. Pedersen JI, Ringstad J, Almendingen K, Haugen TS, Stensvold I, Thelle DS 2000 Adipose tissue fatty acids and risk of myocardial infarction - a case-control study. Eur J Clin Nutr 54:618-625 (Pubitemid 30618023)
19. Sebedio J, Chardigny J 1996 Physiological effects of trans and cyclic fatty acids. In: Perkins E, Erickson M, eds. Deep frying chemistry: nutrition and practical applications. Champaign, IL: AOCS Press; 183-209